A Study to Evaluate the Effect of VX-548 on the QT/QTc Interval in Healthy Participants

NCT05818852 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: VX-548
DRUG: Moxifloxacin
DRUG: Moxifloxacin Placebo
DRUG: VX-548 Placebo

Sponsor

Vertex Pharmaceuticals Incorporated